412 related articles for article (PubMed ID: 26543012)
41. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
42. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
43. Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer.
Liu X; Yun F; Shi L; Li ZH; Luo NR; Jia YF
Asian Pac J Cancer Prev; 2015; 16(15):6201-6. PubMed ID: 26434817
[TBL] [Abstract][Full Text] [Related]
44. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
45. [The TGF-β signaling pathway induced EMT in breast cancer].
Ma Y; Liu H; Zhang H; Shao RG
Yao Xue Xue Bao; 2015 Apr; 50(4):385-92. PubMed ID: 26223118
[TBL] [Abstract][Full Text] [Related]
46. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
47. Direct regulation of transforming growth factor β-induced epithelial-mesenchymal transition by the protein phosphatase activity of unphosphorylated PTEN in lung cancer cells.
Kusunose M; Hashimoto N; Kimura M; Ogata R; Aoyama D; Sakamoto K; Miyazaki S; Ando A; Omote N; Imaizumi K; Kawabe T; Hasegawa Y
Cancer Sci; 2015 Dec; 106(12):1693-704. PubMed ID: 26450531
[TBL] [Abstract][Full Text] [Related]
48. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
49. A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer.
Foroutan M; Cursons J; Hediyeh-Zadeh S; Thompson EW; Davis MJ
Mol Cancer Res; 2017 May; 15(5):619-631. PubMed ID: 28119430
[TBL] [Abstract][Full Text] [Related]
50. Cell Signaling Pathways Related to Epithelial Mesenchymal Transition in Cancer Metastasis.
Inan S; Hayran M
Crit Rev Oncog; 2019; 24(1):47-54. PubMed ID: 31679219
[TBL] [Abstract][Full Text] [Related]
51. SHON, a novel secreted protein, regulates epithelial-mesenchymal transition through transforming growth factor-β signaling in human breast cancer cells.
Li L; Liu DX; Zhang N; Liang Q; Feng J; Yao M; Liu J; Li X; Zhang Y; Lu J; Huang B
Int J Cancer; 2015 Mar; 136(6):1285-95. PubMed ID: 25082541
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathway.
Liu T; Nie F; Yang X; Wang X; Yuan Y; Lv Z; Zhou L; Peng R; Ni D; Gu Y; Zhou Q; Weng Y
Mol Med Rep; 2015 Nov; 12(5):7403-11. PubMed ID: 26459119
[TBL] [Abstract][Full Text] [Related]
53. SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitro.
O'Kane D; Jackson MV; Kissenpfennig A; Spence S; Damkat-Thomas L; Tolland JP; Smyth AE; Denton CP; Stuart Elborn J; McAuley DF; O'Kane CM
Exp Dermatol; 2014 Jul; 23(7):497-503. PubMed ID: 24848428
[TBL] [Abstract][Full Text] [Related]
54. Molecular mechanisms of epithelial-mesenchymal transition.
Lamouille S; Xu J; Derynck R
Nat Rev Mol Cell Biol; 2014 Mar; 15(3):178-96. PubMed ID: 24556840
[TBL] [Abstract][Full Text] [Related]
55. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
56. Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT.
Sisto M; Ribatti D; Lisi S
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670735
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells.
Laurenzana A; Biagioni A; Bianchini F; Peppicelli S; Chillà A; Margheri F; Luciani C; Pimpinelli N; Del Rosso M; Calorini L; Fibbi G
J Mol Med (Berl); 2015 Jul; 93(7):783-94. PubMed ID: 25694039
[TBL] [Abstract][Full Text] [Related]
58. Epidermal Growth Factor Receptor and Transforming Growth Factor β Signaling Pathways Cooperate To Mediate
Igietseme JU; Partin J; George Z; Omosun Y; Goldstein J; Joseph K; Ellerson D; Eko FO; Pohl J; Bandea C; Black CM
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31964750
[TBL] [Abstract][Full Text] [Related]
59. Crosstalk between ERK and MRTF-A signaling regulates TGFβ1-induced epithelial-mesenchymal transition.
Nalluri SM; Sankhe CS; O'Connor JW; Blanchard PL; Khouri JN; Phan SH; Virgi G; Gomez EW
J Cell Physiol; 2022 May; 237(5):2503-2515. PubMed ID: 35224740
[TBL] [Abstract][Full Text] [Related]
60. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
